''Tridelta Development Ltd. specialises in the development, manufacturing and marketing of diagnostic products for the animal health care industry.
The company has commercialised five technologies to date with its "PHASE" range of Acute Phase Protein Assays, which are indicators of the presence of an inflammatory reaction, detected in the blood before the animal shows any physical signs of ill health. Species of specific interest include: cattle, horses, sheep, cats, dogs, pigs and rodents.
Tridelta's ongoing commercial objectives are:
-Further develop and expand existing product lines to increase business with major pharmaceutical companies and research institutions around the world.
-Commercialisation of a new Acute Phase Protein, Mammary Associated Amyloid A (MAA) for "on the farm" diagnosis of Bovine Mastitis, which is a common disease affecting the mammary gland of the cow which reduces the value and volume of the milk produced. The introduction of on-farm MAA testing will provide the farmer with a much needed rapid, simple and accurate method of detecting and treating mastitic infections and of measuring the health of his herd.
-Development of the market for Acute Phase Protein measurement for Animal Welfare and Health Monitoring.''
